ArticleFrontiers in neurology
Headache comorbidity in epilepsy and functional/dissociative seizures: an exploratory cross-sectional study in a tertiary epilepsy center.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Headache disorders are common in patients with epilepsy and functional/dissociative seizures (FDS) and may influence quality of life and clinical outcomes. Migraine has been proposed as a reciprocal risk factor for epileptic and functional seizures. We aimed to determine the prevalence of headache disorders and associated clinical factors in a cohort of patients undergoing video-EEG monitoring at a tertiary epilepsy center. Methods: In this retrospective cross-sectional study, clinical data from 164 adult inpatients evaluated in an epilepsy monitoring unit were analyzed. Headache diagnoses were established using a structured interview based on International Classification of Headache Disorders (ICHD-3) criteria. Associations between headache disorders and clinical variables - including epilepsy subtype, seizure localization, antiseizure medication (ASM), and pre-existing illnesses - were assessed using Fisher's exact tests and logistic regression analyses. Results: Seventy percent of patients were diagnosed with epilepsy and 13% with FDS. Among epilepsy patients, 48% reported headache (21% migraine, 18% tension-type headache), whereas 77% of patients with FDS reported headache (50% migraine, 14% tension-type headache). Epilepsy overall, particularly lesional focal epilepsy, was negatively associated with headache and migraine compared with no-epilepsy patients. In contrast, FDS was positively associated with headache and migraine. Migraine with aura was not disproportionately represented in epilepsy or FDS. Female sex and younger age were associated with headache. Levetiracetam and valproic acid use were negatively associated with migraine. Frontal seizure onset was negatively associated with migraine, whereas temporal onset showed a non-significant positive trend. Obesity was positively associated with migraine with aura, while depression showed a negative association with migraine. Discussion: Headache disorders are frequent in patients undergoing evaluation for paroxysmal neurological disorders, particularly in FDS. Systematic headache screening-especially in young and female patients-may help reduce disease burden. Further studies should clarify shared mechanisms and potential therapeutic implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.